Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients
- 1 July 1988
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 85 (1), 21-30
- https://doi.org/10.1016/0002-9343(88)90171-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Randomized trial of beta-lactam regimens in febrile neutropenic cancer patientsAmerican Journal Of Medicine, 1988
- Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patientsAntimicrobial Agents and Chemotherapy, 1986
- Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteriaAmerican Journal Of Medicine, 1985
- Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancerAmerican Journal Of Medicine, 1985
- Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patientsAmerican Journal Of Medicine, 1984
- Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and staphylococcus aureusInfection, 1984
- SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIAThe Lancet, 1983
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescensAntimicrobial Agents and Chemotherapy, 1981
- Infection Due to Corynebacterium Species in Marrow Transplant PatientsAnnals of Internal Medicine, 1979